[Systemic lupus erythematosus with neurologic onset and secondary antiphospholipid syndrome. A Case Study]

Rev Med Chir Soc Med Nat Iasi. 2005 Apr-Jun;109(2):254-8.
[Article in Romanian]

Abstract

A 39-years-old woman was admitted to our hospital with musculoskeletal complaints (myalgias and symmetric arthralgias in proximal interphalangeal, metacarpophalangeal joints of the hands and in knees), systemic symptoms like fever, fatigue, malaise and a six months previous history of a transient ischemic attack. The presence of antibodies to double-stranded deoxyribonucleic-acid (DNA) and antiphospholipid antibodies led to the diagnosis of systemic lupus erythematosus with secondary antiphospholipid syndrome. Cerebral infarction develops significantly more often in patients with lupus and antiphospholipid antibodies, but other clinical syndromes are associated with lupus anticoagulant: cognitive dysfunction, seizures, polyneuropathy, aseptic meningitis, myelopathy.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adult
  • Anti-Inflammatory Agents / therapeutic use
  • Antibodies, Antinuclear / blood
  • Antibodies, Antiphospholipid / blood
  • Antiphospholipid Syndrome / diagnosis
  • Antiphospholipid Syndrome / drug therapy
  • Antiphospholipid Syndrome / etiology*
  • Antiphospholipid Syndrome / immunology
  • Drug Therapy, Combination
  • Female
  • Humans
  • Immunologic Factors / blood
  • Immunosuppressive Agents / therapeutic use
  • Ischemic Attack, Transient / diagnosis
  • Ischemic Attack, Transient / drug therapy
  • Ischemic Attack, Transient / etiology*
  • Ischemic Attack, Transient / immunology
  • Lupus Erythematosus, Systemic / complications*
  • Lupus Erythematosus, Systemic / diagnosis
  • Lupus Erythematosus, Systemic / drug therapy
  • Lupus Erythematosus, Systemic / immunology
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents
  • Antibodies, Antinuclear
  • Antibodies, Antiphospholipid
  • Immunologic Factors
  • Immunosuppressive Agents